Newport Beach, CA9 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Newport Beach, CA

Find 9 actively recruiting myalgic encephalomyelitis clinical trials in Newport Beach, CA. Connect with local research sites and explore new treatment options.

9
Active Trials
7
Sponsors
1,643
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Newport Beach

RecruitingNewport Beach, CANCT06540833

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo in the trea...

370 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingNewport Beach, CANCT05548296

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial cancer....

353 participants
Acrivon Therapeutics
View Study Details
RecruitingNewport Beach, CANCT06651567

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

This is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in patients with agitation associated with Alzheimer's de...

320 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingNewport Beach, CANCT06190951

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called cemiplimab (each individually called a "study drug" or cal...

150 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingNewport Beach, CANCT07087054

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with ca...

141 participants
Crinetics Pharmaceuticals Inc.
View Study Details
RecruitingNewport Beach, CANCT06624644

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

The goal of this clinical trial is to understand if a new drug called LNS8801 can safely treat patients with melanoma. The primary question to be answered is what is the average length of time during ...

135 participants
Linnaeus Therapeutics, Inc.
View Study Details
RecruitingNewport Beach, CANCT05111574

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

This phase II trial tests whether nivolumab in combination with cabozantinib works in patients with mucosal melanoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's i...

99 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNewport Beach, CANCT05947500

Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial

This phase II trial compares tuvusertib in combination with avelumab to tuvusertib alone to determine whether the combination therapy will lengthen the time before the cancer starts getting worse in p...

50 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNewport Beach, CANCT06514001

A Study of AMDX-2011P in Participants With Alzheimer's Disease

The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with Alzheimer's Disease (AD)....

25 participants
Amydis Inc.
View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Newport Beach

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 9 myalgic encephalomyelitis clinical trials recruiting participants in Newport Beach, CA. These studies are seeking a combined 1,643 participants. Research is being sponsored by Intra-Cellular Therapies, Inc., Acrivon Therapeutics, Regeneron Pharmaceuticals and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Newport Beach — FAQ

Are there myalgic encephalomyelitis clinical trials in Newport Beach?

Yes, there are 9 myalgic encephalomyelitis clinical trials currently recruiting in Newport Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 9 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated March 2, 2026 from ClinicalTrials.gov